Maremmani, I., Dematteis, M., Gorzelanczyk, E. J., Mugelli, A., Walcher, S., & Torrens, M. (2023). Long-acting buprenorphine formulations as a new strategy for the treatment of opioid use disorder.
Citação norma ChicagoMaremmani, Icro, Maurice Dematteis, Edward J. Gorzelanczyk, Alessandro Mugelli, Stephan Walcher, e Marta Torrens. Long-acting Buprenorphine Formulations As a New Strategy for the Treatment of Opioid Use Disorder. 2023.
Citação norma MLAMaremmani, Icro, et al. Long-acting Buprenorphine Formulations As a New Strategy for the Treatment of Opioid Use Disorder. 2023.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.